SURVIVAL-TIME MODELS FOR ANALYZING DRUG-COMBINATION TREATMENTS

被引:0
作者
KUBLER, J
SCHUMACHER, M
机构
[1] Department of Statistics, University of Dortmund, Dortmund, D-4600
[2] Institute of Medical Biometry and Informatics, University of Freiburg, Freiburg, D-7800
关键词
D O I
10.1002/sim.4780091216
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Several relative risk models for survival time data in drug combination therapy are derived and their properties are discussed. The main intention of this paper is to clarify the differences among the models in order to help to choose the appropriate one in a given situation. The models are motivated by discussing their relation to well‐known physiological concepts. In an example of two‐drug treatment the models are compared with each other. For this chemotherapy animal survival study, dose‐risk surfaces are fitted and optimal drug combinations are estimated. Methods for checking the model assumptions are mentioned. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:1527 / 1539
页数:13
相关论文
共 24 条
[1]  
Carter W.H., Wampler G.L., Stablein D., Regression Analysis of Survival Data in Cancer Chemotherapy, (1983)
[2]  
Stablein D., Carter W.H., Wampler G.L., Survival analysis of drug combinations using a hazards model with time‐dependent covariates, Biometrics, 36, pp. 537-546, (1980)
[3]  
Cox D.R., ‘Regression models and life tables’ (with discussion), Journal of the Royal Statistical Society, Series B, 34, pp. 187-220, (1972)
[4]  
Plackett R.L., Hewlett P.S., Quantal response to mixtures of poisons, Journal of the Royal Statistical Society, Series B, 14, pp. 141-163, (1952)
[5]  
Hewlett P.S., Plackett R.L., The Interpretation of Quantal Responses in Biology, (1979)
[6]  
Unkelbach H.-D., Wolf Th., Qualitative Dosis‐Wirkungs‐Analysen, (1985)
[7]  
Loewe S., Muischnek H., Über Kombinationswirkungen. I. Mitteilung: Hilfsmittel der Fragestel‐lung, Naunyn Schmiedebergs, Archiv für experimentelle Pathologie und Pharmakologie, 114, pp. 313-326, (1926)
[8]  
Wolf Th., Unkelbach H.-D., A relationship between two fundamental concepts in drug combination theory, Biometrical Journal, 28, pp. 39-43, (1986)
[9]  
Bliss C.I., The toxicity of poisons applied jointly, Annals of Applied Biology, 26, pp. 585-615, (1939)
[10]  
Berenbaum M.C., Synergy, additivism and antagonism in immunosuppression, Clinical and Experimental Immunology, 28, pp. 1-18, (1977)